Cytosorbents Corp Shares Fall 1.7% Below Previous 52-Week Low - Market Mover
The shares fell 1.7% lower than its previous 52-week low of $4.18, with trading volume higher than its 30 day average
Dec 29, 2021 by Kwhen Finance Editors
Cytosorbents Corp (CTSO) shares closed 1.7% lower than its previous 52 week low, giving the company a market cap of $190M. The stock is currently down 45.0% year-to-date, down 47.3% over the past 12 months, and down 23.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%.
Trading Activity
- Trading volume this week was 2.5% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Cytosorbents Corp | -6.2 | -45.0 | -47.3 | -62.8 | 4.1 |
| Dow Jones Industrial Average | 0.3 | 20.7 | 22.2 | -0.3 | 23.6 |
| S&P 500 Index | -0.1 | 29.4 | 31.1 | 0.1 | 32.7 |
| Health Care | -0.3 | 23.4 | 25.0 | 0.2 | 27.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 3347.7%
- The company's stock price performance over the past 12 months lags the peer average by 2224.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Cytosorbents Corp | CTSO | 0 | -45.0 | -47.3 | -62.8 | 4.1 |
| Peer Avg | N/A | 11.2 | -1.3 | -2.0 | -15.2 | 9.4 |
| Boston Scientific Corp. | BSX | 55.8 | 19.9 | 24.7 | -6.9 | 24.7 |
| Hologic, Inc. | HOLX | 5.2 | 5.5 | 2.8 | ||
| Meridian Bioscience Inc. | VIVO | 6.1 | 6.9 | -1.4 | ||
| Nephros Inc | NEPH | 0 | -28.2 | -23.8 | -46.2 | 4.7 |
| Daxor Corporation | DXR | 0 | -12.0 | -14.5 | -37.9 | 27.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: